TargED Biopharmaceuticals to Present First Clinical and New Preclinical Data on TGD001 in Two Oral Sessions at the 2025 ASH Annual Meeting

Post by: Diane De wyngaert in Press Release TargED
Utrecht, November 3, 2025 -…
read more
03 Nov 2025
0

Tubulis Announces Second Closing of Series C Bringing Total Raised to €344M (US $ 401M)

Post by: Diane De wyngaert in Press Release Tubulis
New investors Fidelity Management &…
read more
30 Oct 2025
0

Tubulis Raises €308 Million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline

Post by: Diane De wyngaert in Press Release Tubulis
• USD 361 million round…
read more
15 Oct 2025
0

EPICS Therapeutics Announces First Cohort Dosed with EP102 in First-In-Patient Oncology Trial and Securement of Additional Financing

Post by: Diane De wyngaert in Epics Therapeutics Press Release
Gosselies, Belgium - September 22nd,…
read more
23 Sep 2025
0

Novadip and Cliniques universitaires Saint-Luc report positive results for compassionate use of NVD003 on four pediatric patients

Post by: Diane De wyngaert in Novadip Press Release
NVD003 is a bone grafting…
read more
08 Jul 2025
0

Novadip receives RMAT designation for NVD003, its regenerative treatment for congenital pseudarthosis of the tibia

Post by: Diane De wyngaert in Novadip Press Release
Novadip is developing NVD003, an…
read more
20 Jun 2025
0

AstriVax Therapeutics Further Strengthens Team with the Appointment of Dieter Weinand as New Chair of the Board of Directors

Post by: Diane De wyngaert in Astrivax Press Release
US-based Dieter Weinand is the…
read more
12 Jun 2025
0

AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using LaunchiT technology

Post by: Diane De wyngaert in Astrivax Press Release
Third asset to advance into…
read more
10 Jun 2025
0

Tubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic

Post by: Diane De wyngaert in Press Release Tubulis
The program, licensed exclusively to…
read more
21 May 2025
0

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Post by: Diane De wyngaert in Novadip Press Release
No refractures were reported during…
read more
29 Apr 2025
0